Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Heat Biologics Inc (HTBX)
Heat Biologics Inc (HTBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Heat Biologics Inc 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 USA

www.heatbio.com P: 919-240-7133

Description:

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell lung cancer, HS-410 for the bladder cancer treatment, HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics, Inc. is based in Chapel Hill, North Carolina.

Key Statistics

Overview:

Market Capitalization, $K 61,047
Shares Outstanding, K 25,650
Annual Sales, $ 2,110 K
Annual Net Income, $ -35,070 K
Last Quarter Sales, $ 610 K
Last Quarter Net Income, $ -13,560 K
60-Month Beta 0.45
% of Insider Shareholders 7.40%
% of Institutional Shareholders 18.12%
Float, K 23,752
% Float 92.60%

Growth:

1-Year Return -65.36%
3-Year Return -65.64%
5-Year Return -95.28%
5-Year Revenue Growth 520.59%
5-Year Earnings Growth 97.16%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 03/14/22
Latest Earnings Date 05/04/22
Earnings Per Share ttm -1.41
EPS Growth vs. Prev Qtr -80.00%
EPS Growth vs. Prev Year -20.34%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 12/11/20

HTBX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -27.90%
Return-on-Assets % -26.13%
Profit Margin % -1,662.09%
Debt/Equity 0.00
Price/Sales 28.77
Price/Cash Flow N/A
Price/Book 0.54
Book Value/Share 4.41
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar